Predicting Response to Neoadjuvant Chemotherapy Using Optical Tomographic Imaging in Women with Breast Cancer

Protocol: 
AAAI0480
Phase: 
Pilot/Feasibility

Predicting Response to Neoadjuvant Chemotherapy Using Optical Tomographic Imaging in Women with Breast Cancer

Are you Eligible? (Inclusion Criteria)

To be eligible for this study, patients must:
- be women of at least 18 years of age
- be deemed eligible to receive neoadjuvant chemotherapy
- have breast cancer (any stage)

Specialty Area(s)

Trial Location

Herbert Irving Comprehensive Cancer Center
161 Fort Washington Ave.
Herbert Irving Pavilion
New York, NY 10032
United States